Jasper Therapeutics, Inc. (JSPR): Cash & Equivalents
$28.69M
As of 2025-12-31
$7.31M
As of 2026-06-30
-9.1%
3-year compound annual growth
+7.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.69M | -59.9% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $71.64M | -17.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $86.89M | +127.2% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $38.25M | -54.8% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $84.70M | +327.0% | 2023-03-08, Balance as of period end |
| 2020-12-31 | $19.84M | n/m | 2022-03-18, Balance as of period end |
| 2019-12-31 | $1.21M | n/a | 2021-05-24, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | 2025-12-31 | $28.69M | -59.9% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $24.75M | +18.3% |
| Viskase Holdings, Inc. (VISK) | 2025-12-31 | $42.57M | -9.1% |
| Windtree Therapeutics Inc (WINT) | 2024-12-31 | $1.78M | -58.8% |
| PharmaCyte Biotech, Inc. (PMCB) | 2026-04-30 | $18.60M | +22.6% |
| Cognition Therapeutics Inc (CGTX) | 2025-12-31 | $36.81M | +47.2% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $16.42M | -66.0% |
| Pluri Inc. (PLUR) | 2026-06-30 | $3.53M | -40.1% |
| Black Hawk Acquisition Corp (BKHA) | 2025-11-30 | $0 | n/a |
Compare JSPR, INMB, VISK, WINT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗